The aim of the symposium was to share learnings from the recently established European Academy of Allergy and Clinical Immunology (EAACI) Task Force on special products for cow’s milk protein allergy (CMPA), with the intention of providing an overview on controversies regarding extensively hydrolysed formulas (eHFs), their utility, and the validity of the definition ‘special products for CMPA1.
Dr Rosan Meyer opened the symposium by discussing the evidence for appropriate dietary management in CMPA, emphasising the importance of breastfeeding and dietary management of breastfed children with CMPA, hypoallergenic formula, and the current controversies and debate around formula choice.
Dr Martinas Kuslys covered the current interpretations and ranges for definitions for eHFs, and presented data from an analytical programme that aims to improve understanding of the wide range of commercially available formulas, with the objective of defining eHFs in a more consistent, meaningful, and practical way.
Prof Antonella Muraro and Prof Arne Høst closed the session with a discussion around the need for updated guidelines to ensure safe products for infants with CMPA, summarising some of the issues with currently available hypoallergenic formulas.1
Read the full symposium notes here.
References:
1. Meyer, R. et al. EMJ Allergy and Immunol. 2017; 2(1): 46–51.
IMPORTANT NOTICE: Mothers should be encouraged to continue breastfeeding even when their infants have cows’ milk protein allergy. This usually requires qualified dietary counselling to completely exclude all sources of cows’ milk protein from the mothers’ diet. If a decision to use a special formula intended for infants is taken, it is important to give instructions on correct preparation methods, emphasising that unboiled water, unsterilised bottles or incorrect dilution can all lead to illness. Formula for special medical purposes intended for infants must be used under medical supervision.
The aim of the symposium was to share learnings from the recently established European Academy of Allergy and Clinical Immunology (EAACI) Task Force on special products for cow’s milk protein allergy (CMPA), with the intention of providing an overview on controversies regarding extensively hydrolysed formulas (eHFs), their utility, and the validity of the definition ‘special products ...